These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13476487)

  • 1. [Treatment of cancer of prostate & its metastases by chlorotrianisene (TACE)].
    HERBEUVAL R; GUILLEMIN P; CUNY G; LARCAN A; BESSOT M
    J Urol Medicale Chir; 1957 Jun; 63(6):422-6. PubMed ID: 13476487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormono- therapy of cancer of the prostate].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():181-91. PubMed ID: 5485068
    [No Abstract]   [Full Text] [Related]  

  • 3. TACE in the treatment of carcinoma of the prostate: an 80-month surgery.
    CARROLL G; BRENNAN RV
    Trans South Cent Sect Am Urol Assoc; 1957; 52():64-6. PubMed ID: 13556886
    [No Abstract]   [Full Text] [Related]  

  • 4. [New advances in hormonal treatment of prostate cancer; the use of chlorotrianisene].
    RAVINA A
    Presse Med (1893); 1955 Sep; 63(59):1198. PubMed ID: 13266742
    [No Abstract]   [Full Text] [Related]  

  • 5. [CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)].
    CALDERINI G; GAGLIARDI V
    Minerva Urol; 1964; 16():53-8. PubMed ID: 14158352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modern trends in the treatment of cancer of the prostate: phosphorylated estrogens].
    CHIEREGO F; FABRIS P
    G Ital Chemioter; 1956; 3(3-4):569-71. PubMed ID: 13462210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of prostate cancer with phosphorylated estrogens (estrol diphosphate)].
    CHIEREGO F; FABRIS P
    Arch Ital Urol; 1956; 29(5):357-83. PubMed ID: 13395753
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary results obtained with hexestrol diphosphate in therapy of prostate cancer].
    COMAR OB; DELLI PAOLI A
    Riforma Med; 1957 Dec; 71(49):1395-9. PubMed ID: 13528575
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorotrianisene (TACE), a physiologic treatment for the climacteric.
    BRUMBAUGH JJ
    Antibiotic Med Clin Ther (New York); 1957 Mar; 4(3):179-82. PubMed ID: 13412073
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with combined hormonal treatment of prostate carcinoma].
    PECHERSTORFER M
    Wien Med Wochenschr; 1959 Feb; 109(6):133-4. PubMed ID: 13648373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical applications of chlorotrianisene (TACE)].
    DARNIS F
    Sem Med Prof Med Soc; 1958 Dec; 34(42-43):1254-5. PubMed ID: 13615381
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological changes in carcinomatous prostate treated with phosphorylated estrogen.
    FABRIS P; CHIEREGO F
    Minerva Urol; 1957; 9(3):109-10. PubMed ID: 13493272
    [No Abstract]   [Full Text] [Related]  

  • 13. TACE in the endocrine management of prostatic carcinoma.
    HEADSTREAM JW; ALLEN DO; JONES BW
    J Am Geriatr Soc; 1957 Apr; 5(4):453-5. PubMed ID: 13428532
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary report on the clinical use of tace (chlorotrianisene) in treatment of prostatic carcinoma.
    SMITH PG; RUSH TW; EVANS AT
    J Urol; 1951 May; 65(5):886-9. PubMed ID: 14841825
    [No Abstract]   [Full Text] [Related]  

  • 15. TACE in prostatic cancer: clinical and biochemical considerations.
    CARROLL G; BRENNAN RV
    J Urol; 1954 Sep; 72(3):497-503. PubMed ID: 13202238
    [No Abstract]   [Full Text] [Related]  

  • 16. TACE in the treatment of carcinoma of the prostate: an 80-month survey.
    CARROLL G; BRENNAN RV
    J Urol; 1958 Aug; 80(2):155-7. PubMed ID: 13564606
    [No Abstract]   [Full Text] [Related]  

  • 17. [New treatments for cancer of the prostate].
    AMIEL C
    Vie Med; 1959 Apr; 40(4):337 passim. PubMed ID: 13659813
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences with chlorotrianisene in the treatment of the menopause.
    HARRIS PG
    Practitioner; 1958 Aug; 181(1082):206-9. PubMed ID: 13567302
    [No Abstract]   [Full Text] [Related]  

  • 19. [Remarks on hormonal treatment of prostatic canecer].
    Verrière P; Burlet P
    J Med Lyon; 1967 May; 48(121):869-70. PubMed ID: 5616975
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recurrent lung metastases in prostate carcinoma and Cyren A implantation].
    LANGE
    Z Urol; 1953; 46(5):333-6. PubMed ID: 13103625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.